159938 医药
已收盘 06-29 15:00:00
资讯
新帖
简况
6月29日百普赛斯涨9.22%，圆信永丰医药健康A基金重仓该股
证券之星 · 16:53
6月29日百普赛斯涨9.22%，圆信永丰医药健康A基金重仓该股
6月29日悦康药业涨5.17%，富国医药创新股票A基金重仓该股
证券之星 · 16:46
6月29日悦康药业涨5.17%，富国医药创新股票A基金重仓该股
雅本化学：公司持续聚焦创新农药、创新医药CDMO两大主业
证券之星 · 16:42
雅本化学：公司持续聚焦创新农药、创新医药CDMO两大主业
6月29日司太立涨6.24%，银河医药混合A基金重仓该股
证券之星 · 16:33
6月29日司太立涨6.24%，银河医药混合A基金重仓该股
新天药业：汇伦医药已向港交所提交上市申请书
证券之星 · 16:27
新天药业：汇伦医药已向港交所提交上市申请书
淘气天尊：双创高位藏险，老登医药大涨！
中金财经 · 15:34
淘气天尊：双创高位藏险，老登医药大涨！
ETF收评 ｜ A股全线收涨，医药、半导体板块联袂走强，科创创新药ETF涨11%、科创半导体ETF涨9%
格隆汇 · 15:09
ETF收评 ｜ A股全线收涨，医药、半导体板块联袂走强，科创创新药ETF涨11%、科创半导体ETF涨9%
鹭燕医药：医保直接结算的加速推进，将有效改善医药流通企业的货款结算环境
证券之星 · 15:06
鹭燕医药：医保直接结算的加速推进，将有效改善医药流通企业的货款结算环境
劲方医药-B午后涨超15% 交银国际维持“买入”评级
新浪港股 · 13:22
劲方医药-B午后涨超15% 交银国际维持“买入”评级
劲方医药-B(02595.HK)：拟不超3.5亿港元回购公司股份
中金财经 · 12:27
劲方医药-B(02595.HK)：拟不超3.5亿港元回购公司股份
医药概念大爆发，盘中多股涨停
大河财立方 · 11:19
医药概念大爆发，盘中多股涨停
礼邦医药(09637)今日登陆港交所：垂直慢病赛道 跑出 Biotech 成长新范式
智通财经 · 10:45
礼邦医药(09637)今日登陆港交所：垂直慢病赛道 跑出 Biotech 成长新范式
新股首日 |“肾病创新药第一股”礼邦医药首挂上市，早盘涨超90%，一手赚2112港元
智通财经 · 10:21
新股首日 |“肾病创新药第一股”礼邦医药首挂上市，早盘涨超90%，一手赚2112港元
医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期
金吾财讯 · 10:20
医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期
礼邦医药首挂上市 股价现涨92.92%
新浪港股 · 10:00
礼邦医药首挂上市 股价现涨92.92%
【新股IPO】礼邦医药－B(09637)首挂开报42.00港元 较招股价高85.84%
金吾财讯 · 09:34
【新股IPO】礼邦医药－B(09637)首挂开报42.00港元 较招股价高85.84%
药明康德完成10亿元股份回购计划；可孚医疗：拟斥资1亿元至2亿元回购公司A股股份｜医药早参
每日经济新闻 · 07:00
药明康德完成10亿元股份回购计划；可孚医疗：拟斥资1亿元至2亿元回购公司A股股份｜医药早参
礼邦医药明日上市：暗盘大涨超90% 募资净额12亿港元 年亏7.5亿
雷递网 · 06-28 18:11
礼邦医药明日上市：暗盘大涨超90% 募资净额12亿港元 年亏7.5亿
每周股票复盘：亚虹医药（688176）23.68%限售股将上市流通
证券之星 · 06-28 02:57
每周股票复盘：亚虹医药（688176）23.68%限售股将上市流通
礼邦医药-B(09637.HK)香港公开发售获963.56倍认购 6月29日上市
中金财经 · 06-26 23:07
礼邦医药-B(09637.HK)香港公开发售获963.56倍认购 6月29日上市
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.61,"timestamp":1782716613000,"preClose":0.573,"halted":0,"volume":149633100,"delay":0,"changeRate":0.0646,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.037,"latestTime":"06-29 15:00:00","open":0.573,"high":0.61,"low":0.564,"amount":88930000,"amplitude":0.0803,"askPrice":0.61,"askSize":20355,"bidPrice":0.609,"bidSize":1080,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782783000000},"marketStatusCode":5,"adr":0,"adjPreClose":0.573,"symbolType":"fund","openAndCloseTimeList":[[1782696600000,1782703800000],[1782709200000,1782716400000]],"highLimit":0.63,"lowLimit":0.516,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.745952,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938","defaultTab":"news","newsList":[{"id":"2647322190","title":"6月29日百普赛斯涨9.22%，圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322190?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:53","pubTimestamp":1782723231,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日百普赛斯涨9.22%，收盘报47.75元，换手率8.01%，成交量10.1万手，成交额4.66亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.66亿元，最新净值1.6714，较上一交易日下跌4.03%，近一年下跌3.56%。圆信永丰医药健康A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","159938","150219","BK1574","BK1515","BK0216","301080","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322503","title":"6月29日悦康药业涨5.17%，富国医药创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322503?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:46","pubTimestamp":1782722800,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日悦康药业涨5.17%创60日新低，收盘报13.01元，换手率3.43%，成交量15.42万手，成交额1.98亿元。重仓悦康药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为富国基金的富国医药创新股票A。富国医药创新股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","BK0239","159938","BK1515","09939","688658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322333","title":"雅本化学：公司持续聚焦创新农药、创新医药CDMO两大主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322333?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:42","pubTimestamp":1782722547,"startTime":"0","endTime":"0","summary":"证券之星消息，雅本化学(300261)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问公司有没有考虑向集成电路、芯片及高端材料方向转型的计划？雅本化学回复：尊敬的投资者，您好！公司持续聚焦创新农药、创新医药CDMO两大主业，关于公司的业务布局和战略方向，请以公司在巨潮资讯网发布的定期报告和临时公告为准。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","300261","BK0174","BK1574","BK0028","BK1161","09939","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647532449","title":"6月29日司太立涨6.24%，银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647532449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647532449?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:33","pubTimestamp":1782721992,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日司太立涨6.24%，收盘报10.89元，换手率7.89%，成交量34.58万手，成交额3.7亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为银河基金的银河医药混合A。方伟在任的基金产品包括:银河康乐股票A，管理时间为2021年5月10日至今，期间收益率为-34.9%；银河医药混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09939","BK1161","159938","603520","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647654324","title":"新天药业：汇伦医药已向港交所提交上市申请书","url":"https://stock-news.laohu8.com/highlight/detail?id=2647654324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647654324?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:27","pubTimestamp":1782721628,"startTime":"0","endTime":"0","summary":"证券之星消息，新天药业(002873)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司实控人有没有考虑把他手中的汇伦医药股份注入新天药业，新天药业回复：您好，据从汇伦医药方面了解，其前期已向港交所提交了上市申请书，详情可查阅香港联合交易所披露易平台（http://www.hkexnews.hk）的官方公告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HEXmain","BK1574","BK1161","BK0239","002873","BK1515","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647329738","title":"淘气天尊：双创高位藏险，老登医药大涨！","url":"https://stock-news.laohu8.com/highlight/detail?id=2647329738","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647329738?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:34","pubTimestamp":1782718446,"startTime":"0","endTime":"0","summary":"各位淘粉们，大家收盘好！早盘沪指平开于4026点，创业板高开6点于4200点，两市1746股上涨、2990股下跌，开局还算温和！但随后市场便迅速进入了极致分化的节奏：科创50一骑绝尘，大涨超4%，创业板紧随其后奋力奔跑，然而黄线却一头栽倒、持续低迷，两市上涨个股一度仅剩1000家左右！之后双双翻绿的双创指数也逐步翻红领涨翘尾，科创50指数再创反弹新高，盘尾各大指数均不同程度翘尾收于全天相对高位区域！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangjuejin/20260629/32293063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","159938","BK1161","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326780","title":"ETF收评 ｜ A股全线收涨，医药、半导体板块联袂走强，科创创新药ETF涨11%、科创半导体ETF涨9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326780","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647326780?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:09","pubTimestamp":1782716985,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["512480","159582","159938","399300","159982","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647326747","title":"鹭燕医药：医保直接结算的加速推进，将有效改善医药流通企业的货款结算环境","url":"https://stock-news.laohu8.com/highlight/detail?id=2647326747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647326747?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:06","pubTimestamp":1782716795,"startTime":"0","endTime":"0","summary":"证券之星消息，鹭燕医药06月29日在投资者关系平台上答复投资者关心的问题。但在推进期内，也同时存在前期存量账款结算周期拉长的转型期矛盾。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900016756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","002788","BK0250","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647323800","title":"劲方医药-B午后涨超15% 交银国际维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647323800","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647323800?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:22","pubTimestamp":1782710520,"startTime":"0","endTime":"0","summary":" 劲方医药-B午后股价上涨15.06%，现报27.96港元，成交额4010.55万港元。 据劲方医药官微消息，公司宣布GFH375/VS-7375进入一项II期海外研究，治疗KRAS G12D突变型转移性胰腺导管腺癌，并已于近日完成首例患者入组。 交银国际发布研报称，将劲方医药的投资评级及目标价，分别维持“买入”评级及目标价51港元。该行称，KRAS G12D 抑制剂海外临床及合作进展理想。交银国际认为,优异的海外初步数据对 VS7375 的同类最佳潜性提供进一步佐证。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-06-29/doc-inifacku5422211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02595","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647285693","title":"劲方医药-B(02595.HK)：拟不超3.5亿港元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2647285693","media":"中金财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647285693?lang=zh_cn&edition=full","pubTime":"2026-06-29 12:27","pubTimestamp":1782707222,"startTime":"0","endTime":"0","summary":"格隆汇6月29日丨劲方医药-B(02595.HK)公布，2026年6月29日，董事会正式决议行使购回股份授权，拟不定时于公开市场购回H股，最高金额不超过3.5亿港元，股份购回期限至购回股份授权期限届满。公司会在符合香港联合交易所有限公司证券上市规则的情况下进行股份购回。\r\n\r\n 董事会认为，目前股份的交易价格低估了公司的内在价值及发展前景，而进行股份购回将提升股东价值。股份购回表明董事会对公司长期发展的信心，且仅会在董事会经持续评估公司业务前景、财务状况、股价表现及市场环境，认为适当且符合公司及股东整体利益的情况下进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260629/32292864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1515","09939","159938","BK1574","02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647408513","title":"医药概念大爆发，盘中多股涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2647408513","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647408513?lang=zh_cn&edition=full","pubTime":"2026-06-29 11:19","pubTimestamp":1782703180,"startTime":"0","endTime":"0","summary":"【大河财立方消息】6月29日，A股医药概念集中爆发，CRO、创新药、医疗服务、减肥药、仿制药、抗生素等全链条大幅拉升。个股方面，凯莱英、广生堂、三生国健、双鹭药业、科伦药业、海思科、津药药业、太龙药业等批量涨停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293786389250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","09939","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647477123","title":"礼邦医药(09637)今日登陆港交所：垂直慢病赛道 跑出 Biotech 成长新范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2647477123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647477123?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:45","pubTimestamp":1782701102,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月29日，礼邦医药 - B正式在港交所主板挂牌，成为港股市场首家纯肾病赛道的 18A 创新药企。截至发稿时，礼邦医药股价44.8港元，涨超98%，市值超过150亿港元。这种 “慢赛道里的强卡位”，是 Biotech 最扎实的安全垫：肾病患者用药周期长达数年至十余年，依从性稳定、复购率高，单患者全生命周期价值远高于多数肿瘤适应症；且赛道竞争缓和，无需面对激烈的价格战，更易形成稳定、可预测的现金流模型。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","XBI","BK4588","BK1574","BK4585","BK1161","HEXmain","159938","BK4581","BK1515","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647394342","title":"新股首日 |“肾病创新药第一股”礼邦医药首挂上市，早盘涨超90%，一手赚2112港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647394342","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647394342?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:21","pubTimestamp":1782699706,"startTime":"0","endTime":"0","summary":"礼邦医药-B今日首挂上市，发行价22.6港元，每手100股，集资净额约11.81亿港元。公司聚焦肾病疗法，核心产品AP301用于治疗高磷血症，已完成中国III期注册临床试验，预计近期提交新药申请，并正在中美推进全球III期关键临床试验。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/477792228558ae5ee6ba159bc242b6a4","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/477792228558ae5ee6ba159bc242b6a4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460114.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1515","BK1161","159992","IPOS","09637","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647034208","title":"医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2647034208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647034208?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699626,"startTime":"0","endTime":"0","summary":"消息面上，东吴证券研究指，22家CXO上市公司2026Q1实现收入、归母净利润、扣非归母净利润总额增速分别同比增长18.6%、21.9%、63.5%，业绩逐季度改善。根据医药魔方，2026Q1，国内创新药一级市场融资总金额25.9亿美元，同比上涨128.6%，2026Q1中国相关交易数量及金额涨势迅猛，总金额达614亿美元，大幅领先国外交易总金额。该机构认为，随着中国创新药在全球研发创新中的比重提升，与其配套的CXO产业链将进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU0181495838.USD","HK0000320264.USD","LU0588546209.SGD","03347","LU2045819591.USD","LU1880383366.USD","LU0417516902.SGD","LU2242644610.SGD","LU0140636845.USD","159938","LU0823426308.USD","02359","LU0359202008.SGD","LU0326950275.SGD","LU0516422952.EUR","LU1242518931.SGD","09939","03759","LU0417516738.SGD","HK0000306685.HKD","LU0052750758.USD","603127","BK1583","LU0979878070.USD","LU1688375341.USD","LU2125910500.SGD","BK1141","BK1161","BK0216","LU3063872942.SGD","LU0348767384.USD","01548","BK1574","LU0348825331.USD","LU0043850808.USD","06127","HK0000320223.HKD","LU1794554557.SGD","BK1191","LU0348735423.USD","HK0000306701.USD","LU0320764599.SGD","02269","LU0456846285.SGD","LU0708995583.HKD","06821","BK1576","LU1720050803.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647342994","title":"礼邦医药首挂上市 股价现涨92.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647342994","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647342994?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:00","pubTimestamp":1782698400,"startTime":"0","endTime":"0","summary":" 礼邦医药-B首挂上市，公告显示，每股定价22.6港元，共发行5675.54万股股份，每手100股，所得款项净额约11.81亿港元。截至发稿，股价上涨92.92%，现报43.60港元，成交额3.33亿港元。 其中，核心产品AP301被中国列为一类新药。AP301是一款用于治疗高磷血症的磷结合剂。高磷血症是在接受透析的 CKD患者中CKD最常见的并发症之一，存在大量未被满足的医疗需求。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2026-06-29/doc-iniezsvf0332789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1515","BK1161","BK1574","09939","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647344760","title":"【新股IPO】礼邦医药－B(09637)首挂开报42.00港元 较招股价高85.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647344760","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647344760?lang=zh_cn&edition=full","pubTime":"2026-06-29 09:34","pubTimestamp":1782696861,"startTime":"0","endTime":"0","summary":"金吾财讯 | 礼邦医药－B(09637)首挂开报42.00港元，较招股价高85.84%，盘前成交额2.69亿港元。不计手续费，每手100股，账面赚1940港元。据招股结果显示，股份最终发售价厘定为每股22.60港元，香港公开发售获大幅超额认购，有效申请145,729份，认购倍数约963.56倍，一手中签率为6.00%。国际发售获适度超额认购，认购倍数约19.77倍。","market":"fut","thumbnail":"https://static.szfiu.com/news/20220324/YjY3NDkzOTMxMjg3NTcxMDI1Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/YjY3NDkzOTMxMjg3NTcxMDI1Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984672","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09637","BK1161","09939","EWH","BK1574","159938","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349651","title":"药明康德完成10亿元股份回购计划；可孚医疗：拟斥资1亿元至2亿元回购公司A股股份｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349651","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647349651?lang=zh_cn&edition=full","pubTime":"2026-06-29 07:00","pubTimestamp":1782687659,"startTime":"0","endTime":"0","summary":"丨2026年6月29日星期一丨NO.1药明康德：完成10亿元股份回购计划6月26日，药明康德公告称，公司已完成2026年股份回购计划，累计回购A股股份970.12万股，占总股本0.33%，实际回购金额10亿元，回购价格区间为95.11元/股至118.48元/股。回购股份将用于员工持股计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293785660098.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293785660098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2242644610.SGD","LU2045819591.USD","BK1100","01187","BK0251","LU0708995583.HKD","LU1719994722.HKD","BK1583","LU1969619763.USD","LU2495084118.USD","LU2125910500.SGD","BK1574","IE00BPRC5H50.USD","LU0052750758.USD","301087","LU1046422090.SGD","LU0320764599.SGD","BK1141","LU0456842615.SGD","603259","BK1161","LU1997244956.HKD","BK0216","LU1979443071.USD","LU1934453819.USD","LU1997245094.SGD","LU2328871848.SGD","LU2488822045.USD","LU0348767384.USD","LU1997245177.USD","09939","LU1808992512.USD","159982","BK1515","BK1576","LU1770034418.SGD","LU1251922891.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","399300","LU0348766576.USD","LU1303224171.USD","02359","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646312378","title":"礼邦医药明日上市：暗盘大涨超90% 募资净额12亿港元 年亏7.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2646312378","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646312378?lang=zh_cn&edition=full","pubTime":"2026-06-28 18:11","pubTimestamp":1782641512,"startTime":"0","endTime":"0","summary":"礼邦医药(江苏)股份有限公司（简称：“礼邦医药”，股票代码：“09637”）将于明日在港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260628/6391826709463730032591764.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260628/6391826709463730032591764.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34183/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK1161","IPOS","09939","BK1515","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646031302","title":"每周股票复盘：亚虹医药（688176）23.68%限售股将上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2646031302","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646031302?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:57","pubTimestamp":1782586627,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，亚虹医药报收于9.19元，较上周的10.18元下跌9.72%。本周，亚虹医药6月23日盘中最高价报10.31元。6月26日盘中最低价报9.17元。亚虹医药当前最新总市值52.58亿元，在化学制药板块市值排名81/150，在两市A股市值排名3029/5206。涉及股东为PAN KE和ZHUANG CHENGFENG JOHN，分别持有129,465,348股和6,019,189股，解除限售后剩余限售股数量为0。上述股份锁定期为公司上市之日起三个完整会计年度后6个月，相关股东已严格履行限售承诺，保荐机构中信证券无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","159938","BK1515","BK0239","BK1574","BK1161","688176"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646636649","title":"礼邦医药-B(09637.HK)香港公开发售获963.56倍认购 6月29日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2646636649","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646636649?lang=zh_cn&edition=full","pubTime":"2026-06-26 23:07","pubTimestamp":1782486421,"startTime":"0","endTime":"0","summary":"格隆汇6月26日丨礼邦医药-B(09637.HK)公告，公司全球发售56,755,400股H股，每股H股22.60港元，所得款项净额11.81亿港元。香港公开发售股份数目占全球发售股份数目10%，获认购963.56倍；国际发售股份数目占全球发售股份90%，获认购倍19.77倍。\r\n\r\n 假设全球发售于2026年6月29日(星期一)上午八时正或之前(香港时间)成为无条件，预期H股将于2026年6月29日(星期一)上午九时正(香港时间)开始在联交所买卖。H股将以100股H股为一手买卖单位进行交易，H股的股份代号为09637。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260626/32291951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159938","IPOS","09637","BK1161","09939","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782741746743,"stockEarnings":[{"period":"1week","weight":0.0053},{"period":"1month","weight":-0.0466},{"period":"3month","weight":-0.0934},{"period":"6month","weight":-0.1357},{"period":"1year","weight":-0.0919},{"period":"ytd","weight":-0.1171}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}